Sanofi's Multiple Sclerosis Drug Approved in Europe After FDA Rejection
A multiple sclerosis treatment from Sanofi has received a positive review in Europe, marking a notable shift after its rejection by the FDA last year.
Editorial Staff Apr 24
Medicine
Latest Medicine stories from Life.
Embarking on a Medical Career at 72: A Journey of Resilience
Dawn Zuidegeest-Craft shares her experience of starting medical school at 69 and now preparing for residency at 72, highlighting the challenges and lessons learned.
Editorial Staff Apr 24
Trump Administration's Shift on Drug Policy: Embracing Psychedelics and Cannabis
In a notable shift from previous GOP stances, the Trump administration is now supporting research into psychedelics and reconsidering marijuana's legal status.
Editorial Staff Apr 23
Trump's Reclassification of Medical Marijuana Marks a Significant Policy Change
In a notable policy shift, President Trump has reclassified state-licensed medical marijuana as a less-dangerous drug, a change that advocates have long pursued.
Editorial Staff Apr 23
Colorado and Virginia Legislatures Push Back Against Drug Affordability Board Restrictions
Legislators in Colorado and Virginia are opposing efforts to limit the powers of prescription drug affordability boards, highlighting a significant debate over drug pricing strategies.
Editorial Staff Apr 23
New Medicare Pathway Proposed for Breakthrough Medical Devices by CMS and FDA
Federal regulators are set to unveil a new Medicare coverage pathway aimed at accelerating access to FDA-designated breakthrough medical devices, enhancing treatment options for patients.
Editorial Staff Apr 23
RFK Jr. Adjusts Stance on Vaccinations and Pharma Deals
In a recent shift, RFK Jr. has expressed support for vaccinations while also defending his previous secret agreements with pharmaceutical companies.
Editorial Staff Apr 23
Future of Medical Radioisotope Supply Discussed at NEA Workshop
The Nuclear Energy Agency (NEA) recently convened a workshop to explore advancements and challenges in the supply of medical radioisotopes.
Editorial Staff Apr 23
Biotech Update: RevMed, Roche, and Kyverna CAR-T Therapy Insights
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.
Editorial Staff Apr 22
Exploring the Complex Narratives Behind Pharmaceutical Innovations
Thomas Goetz emphasizes that each drug represents a broader narrative involving health, medicine, society, and economics.
Editorial Staff Apr 22
Roche Pursues Regulatory Approval for MS Drug Despite Ongoing Safety Concerns
Roche is advancing its experimental multiple sclerosis drug to regulators following successful trials, though significant safety concerns persist.
Editorial Staff Apr 21
Purdue Pharma's $225 Million Forfeiture Paves the Way for Settlement Finalization
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
Editorial Staff Apr 21
Purdue Pharma to Forfeit $225 Million in Settlement with Justice Department
A U.S. judge is anticipated to order Purdue Pharma to forfeit $225 million, marking a significant step in ongoing legal proceedings.
Editorial Staff Apr 21
Understanding the Ongoing Battle Over Drug Price Transparency
A closer look at the ongoing disputes surrounding drug price transparency and the role of pharmacy benefit managers (PBMs) in this contentious issue.
Editorial Staff Apr 20
Trump Advocates for Psychedelic Treatments and Weight-Loss Drug Developments
In recent pharmaceutical news, Trump has shown support for psychedelic treatment options while discussions continue regarding the future of weight-loss drugs.
Editorial Staff Apr 20
Nektar Therapeutics Drug Shows Potential for Alopecia Treatment
Recent findings suggest that prolonged use of a drug from Nektar Therapeutics may encourage hair growth in individuals suffering from alopecia.
Editorial Staff Apr 20
Pharmacy Benefit Managers Challenge Trump's Drug Price Transparency Proposal
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
Editorial Staff Apr 20
Insights from AACR 2026: Progress in KRAS Drug Development by Revolution Medicines
The American Association of Cancer Researchers' annual meeting showcases significant advancements in the development of KRAS-targeting therapies, particularly by Revolution Medicines.
Editorial Staff Apr 19
Zai Lab and Amgen Collaborate on Lung Cancer Therapy Evaluation
Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.
Editorial Staff Apr 19
Ultragenyx's Gene Therapy for Sanfilippo Syndrome Receives FDA Acceptance
The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.
Editorial Staff Apr 19